Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Ofiara

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Diagnostic Cytopathology|September 13, 2017
Off the beaten path: A case of mediastinal ectopic thyroid tissueCatherine Robitaille, Linda Ofiara, Manon Auger
Journal of Thoracic Disease|July 10, 2020
Bronchoscopic tissue yield for advanced molecular testing: are we getting enough?Pattraporn Tajarernmuang, Linda Ofiara, Stéphane Beaudoin, et al.
BMC Pulmonary Medicine|December 9, 2017
Impact of rapid investigation clinic on timeliness of lung cancer diagnosis and treatmentNicole Ezer, Asma Navasakulpong, Kevin Schwartzman, et al.
Chest|March 6, 2021
Real-World Outcomes of Patients With Advanced Non-small Cell Lung Cancer Treated With Anti-PD1 Therapy on the Basis of PD-L1 Results in EBUS-TBNA vs Histological SpecimensPattraporn Tajarernmuang, Linda Ofiara, Stéphane Beaudoin, et al.
Clinical Lung Cancer|March 28, 2017
Long-term Outcomes of Induction Carboplatin and Gemcitabine Followed by Concurrent Radiotherapy With Low-dose Paclitaxel and Gemcitabine for Stage III Non-small-cell Lung CancerCatherine Guilbault, Aurelie Garant, Sergio Faria, et al.
Cancer|April 25, 2003
Weekly paclitaxel and gemcitabine chemotherapy for metastatic non-small cell lung carcinoma (NSCLC): a dose-optimizing phase II trialVera Hirsh, Renaud Whittom, Linda Ofiara, et al.
Journal of Bronchology & Interventional Pulmonology|September 13, 2019
Programmed Death Ligand 1 Testing of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Samples Acquired For the Diagnosis and Staging of Non-Small Cell Lung CancerAllister Smith, Hangjun Wang, Alix Zerbo, et al.
Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
Sequential therapy with Vinorelbine followed by Gemcitabine in patients with metastatic non small cell lung cancer (NSCLC), performance status (PS) 2, or elderly with comorbidities--a multicenter phase II trialVera Hirsh, Jean Latreille, Harvey Kreisman, et al.
Chest|September 22, 2023
Accuracy of Cytologic vs Histologic Specimens for Assessment of Programmed Cell Death Ligand-1 Expression in Non-Small Cell Lung Cancer: A Systematic Review and Meta-AnalysisPattraporn Tajarernmuang, Felipe Aliaga, Amr J Alwakeel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2007
Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancerVera Hirsh, Denis Soulieres, Marie Duclos, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Diagnostic Cytopathology|September 13, 2017
Off the beaten path: A case of mediastinal ectopic thyroid tissueCatherine Robitaille, Linda Ofiara, Manon Auger
Journal of Thoracic Disease|July 10, 2020
Bronchoscopic tissue yield for advanced molecular testing: are we getting enough?Pattraporn Tajarernmuang, Linda Ofiara, Stéphane Beaudoin, et al.
BMC Pulmonary Medicine|December 9, 2017
Impact of rapid investigation clinic on timeliness of lung cancer diagnosis and treatmentNicole Ezer, Asma Navasakulpong, Kevin Schwartzman, et al.
Chest|March 6, 2021
Real-World Outcomes of Patients With Advanced Non-small Cell Lung Cancer Treated With Anti-PD1 Therapy on the Basis of PD-L1 Results in EBUS-TBNA vs Histological SpecimensPattraporn Tajarernmuang, Linda Ofiara, Stéphane Beaudoin, et al.
Clinical Lung Cancer|March 28, 2017
Long-term Outcomes of Induction Carboplatin and Gemcitabine Followed by Concurrent Radiotherapy With Low-dose Paclitaxel and Gemcitabine for Stage III Non-small-cell Lung CancerCatherine Guilbault, Aurelie Garant, Sergio Faria, et al.
Cancer|April 25, 2003
Weekly paclitaxel and gemcitabine chemotherapy for metastatic non-small cell lung carcinoma (NSCLC): a dose-optimizing phase II trialVera Hirsh, Renaud Whittom, Linda Ofiara, et al.
Journal of Bronchology & Interventional Pulmonology|September 13, 2019
Programmed Death Ligand 1 Testing of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Samples Acquired For the Diagnosis and Staging of Non-Small Cell Lung CancerAllister Smith, Hangjun Wang, Alix Zerbo, et al.
Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
Sequential therapy with Vinorelbine followed by Gemcitabine in patients with metastatic non small cell lung cancer (NSCLC), performance status (PS) 2, or elderly with comorbidities--a multicenter phase II trialVera Hirsh, Jean Latreille, Harvey Kreisman, et al.
Chest|September 22, 2023
Accuracy of Cytologic vs Histologic Specimens for Assessment of Programmed Cell Death Ligand-1 Expression in Non-Small Cell Lung Cancer: A Systematic Review and Meta-AnalysisPattraporn Tajarernmuang, Felipe Aliaga, Amr J Alwakeel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2007
Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancerVera Hirsh, Denis Soulieres, Marie Duclos, et al.
Pageof 2